Valo Therapeutics
PrivateLast Round
VC Round
Mar 10, 2025
Total Funding Raised
$24.37M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Valo Therapeutics operates in Healthcare & Life Sciences and is based in Helsinki. Its latest recorded funding round was a VC Round in March 2025.
Valo Therapeutics is a biotechnology company that develops novel immunotherapies for cancer and infectious diseases using its proprietary PeptiCRAd platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valo Therapeutics Comparables
Compare Valo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TILT Biotherapeutics | 89% | |
| GeneMedicine | 83% | |
| Nouscom | 83% |
For institutional investors. Book with your work email.
Valo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 10, 2025 | ||||
| Grant | Feb 14, 2023 | ||||
| Private Equity | Nov 15, 2021 | ||||
| Seed | Feb 6, 2020 | ||||
| Debt | Jul 4, 2017 | ||||
Seed | Jan 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Valo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Freeman Road | VC Round |
| European Innovation Council Fund | Grant |
| Business Finland | Debt |
| Indaco Venture Partners SGR | VC Round |
| CDP Venture Capital SGR | VC Round |
| ENEA-Tech and Biomedical Foundation | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2026
Monthly visitors grew 216% MoM, from 1.1K to 3.6K.
- Jul 24, 2026
Monthly visitors grew 34% MoM, from 674 to 900.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 6, 2026
Valo Therapeutics LTD hires Carlos de Sousa as Chief Executive Officer to lead its next phase of clinical and corporate development.
For institutional investors. Book with your work email.
Valo Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Valo Therapeutics's valuation, stock price, and market status.
Is Valo Therapeutics a public or private company?
Valo Therapeutics is a private company.
What is the current stock price of Valo Therapeutics?
Valo Therapeutics is a private company, so its shares have no public market price. Caplight tracks Valo Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Valo Therapeutics worth (valuation)?
Valuation information for Valo Therapeutics is not publicly available.
Can I buy Valo Therapeutics stock?
Valo Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Valo Therapeutics's last funding round?
Valo Therapeutics's most recent funding round was VC Round on March 10, 2025.
Who are the main investors in Valo Therapeutics?
Key investors in Valo Therapeutics include Indaco Venture Partners SGR, CDP Venture Capital SGR.
Will Valo Therapeutics IPO soon?
No public IPO plans have been announced for Valo Therapeutics.
How can I track Valo Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Valo Therapeutics's shares on secondary markets.